Ashish Ranjan to Antineoplastic Agents
This is a "connection" page, showing publications Ashish Ranjan has written about Antineoplastic Agents.
Connection Strength
1.607
-
Biodistribution and Efficacy of Low Temperature-Sensitive Liposome Encapsulated Docetaxel Combined with Mild Hyperthermia in a Mouse Model of Prostate Cancer. Pharm Res. 2016 10; 33(10):2459-69.
Score: 0.356
-
Neoantigen activation, protein translocation and targeted drug delivery in combination with radiotherapy. Ther Deliv. 2016 06; 7(6):377-85.
Score: 0.354
-
Hyperthermia sensitization and proton beam triggered liposomal drug release for targeted tumor therapy. Pharm Res. 2014 Nov; 31(11):3120-6.
Score: 0.308
-
MRI-guided monitoring of thermal dose and targeted drug delivery for cancer therapy. Pharm Res. 2013 Nov; 30(11):2709-17.
Score: 0.289
-
A multilayer network-enabled ultrasonic image series analysis approach for online cancer drug delivery monitoring. Comput Methods Programs Biomed. 2022 Jan; 213:106505.
Score: 0.129
-
Nanoformulations for therapy of pancreatic and liver cancers. Nanomedicine (Lond). 2015 May; 10(9):1515-34.
Score: 0.082
-
Tumor Spheroids as an in vitro model for determining the therapeutic response to proton beam radiotherapy and thermally sensitive nanocarriers. Theranostics. 2013; 3(9):687-91.
Score: 0.073
-
Combinatorial nanoparticles for cancer diagnosis and therapy. Curr Med Chem. 2012; 19(22):3714-21.
Score: 0.016